Abstract
Introduction: Parallel with the emerging results of the FAST-Forward (FF) trial, we implemented ultrahypofractionated radiation therapy (RT) for early-stage breast cancer in our clinic at the beginning of the COVID-19 pandemic [Brunt 2020]. This scheme of 26 Gy in 5 consecutive fractions, was given to all breast cancer patients referred for postoperative RT of the breast only. Uniquely, in view of the pandemic, we also gave a single ultrahypofractionated sequential tumourbed boost of 6 Gy, if indicated according to our local protocol.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
